NCT04999124Completed
Characteristics of NAFLD Among Type 2 Diabetes Patients
Study of the Characteristics of Non-Alcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Mellitus Patients Followed in a Hospital Environment in Flanders, Belgium
Source: ClinicalTrials.gov · Last updated 4 Sept 2026
Brief summary (registry, in English)
Type 2 diabetes patients have a high risk of developing NAFLD. This was confirmed during previous research, a high prevalence of NAFLD among type 2 diabetes mellitus patients was found. The investigators want to determine the characteristics of this population.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 1762 (actual)
- First submitted
- 26 Nov 2020
- Start date
- 1 Jan 2020
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- Ziekenhuis Oost-Limburg
- NCT number
- NCT04999124
What you commit to
- Study type: Interventional
- Participants enrolled: 1762
- From 1 Jan 2020 to the primary completion date, 30 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- other liver disease,
Other
- excessive alcohol abuse,
- secondary causes of steatosis
Who the study is looking for
- 18-80 years,
- having type 2 diabetes,
- able to understand Dutch,
- able to understand the informed consent
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ziekenhuis Oost-Limburg Coordinator of this site? Confirm its status | Genk | Belgium | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.